Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.
about
Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR dataThe determination of melanoma stage at diagnosisMelanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the worldThe determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate.Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma.Increasing incidence of melanoma among middle-aged adults: an epidemiologic study in Olmsted County, Minnesota.Cutaneous melanoma in situ: translational evidence from a large population-based studyIncreases in invasive melanoma in England, 1979-2006, by anatomical site.Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006.Incidence of childhood and adolescent melanoma in the United States: 1973-2009Environmental risk factors for relapse of melanomaSerum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.The long non-coding RNA NKILA inhibits the invasion-metastasis cascade of malignant melanoma via the regulation of NF-ĸB.Socioeconomic and lifestyle factors and melanoma: a systematic review.Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.Metastatic pathways in patients with cutaneous melanoma.Cutaneous melanoma in Iceland: changing Breslow's tumour thickness.Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?Epidemiology of melanoma: is it still epidemic? What is the role of the sun, sunbeds, Vit D, betablocks, and others?Melanoma incidence and mortality in Europe: new estimates, persistent disparities.Up-to-date results on survival of patients with melanoma in Germany.Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.Cancer incidence and mortality patterns in women with anorexia nervosa.miR‑367 enhances the proliferation and invasion of cutaneous malignant melanoma by regulating phosphatase and tensin homolog expression.Lentigos, Melanocytic Naevi and Melanoma
P2860
Q33483893-4D32518E-0260-43CF-93BF-61797E011616Q34002931-B7B5AEAB-5FBF-4177-91F0-EA93704EA227Q34071271-71FD4F00-942F-43D4-9099-1A95AC7512B7Q34895156-99131DA6-DDF3-42F9-BADE-95567C1FE63AQ35222359-F953EEB2-E2E7-49A7-80F7-AA61DA890039Q35275296-B65EB3CC-183F-4A9D-BF30-0BD972A5700DQ35318086-86D2A679-ECEA-4065-A8D6-731B6735D163Q35584985-0F8524F6-B55C-4429-99B1-0F821342E3CAQ36124227-688F9A43-AA1A-4091-89FB-104C37CB2DBAQ36344098-7130C7B5-8FD7-47F0-8BC2-693CA3224DEAQ36804250-2F115759-0D96-4F8F-BEE8-635CCB48D02AQ36973557-42C20513-89DE-4591-9AE2-1DB9E29D7E50Q37411677-67A243D0-E937-4961-98A7-423DCF32BACEQ37596814-60CAD163-2025-4945-A910-64343660C22DQ38263679-D041A6E8-72D6-40B3-B9E6-DA535366805AQ38886301-57F2AEA9-32FE-4F07-85A8-6460F75E5883Q39024316-9825C5A9-50DB-41D5-86BD-E528564E1DF7Q39178785-5716A67B-13DB-4DA2-A9B4-567E448870AFQ40054249-DC1A7B19-7050-4C91-9D66-74270E53E38FQ40845888-851707CD-4023-47C2-8A4C-4E4093A79948Q43544136-4C797211-8AE8-4702-8413-6AA30D1A8BA7Q43604521-5F982FBB-DD6A-4263-91F1-FEA409269554Q44322484-8397268C-025B-44A7-B5E2-CF875984F8F7Q45289193-F902C658-E713-4CFD-9572-448B585330C0Q45925229-6F20700F-12E1-4113-B129-2D46C13CF880Q51163666-D84E88A9-5440-414B-9D2C-ED9300B83DFEQ54785364-04F05C80-8722-40C6-91E4-557F35DCC044Q55044006-83F63150-42E1-4E58-BD07-043A33FFFE0DQ56828381-81718E6C-447C-481F-976E-2FE4765D07EF
P2860
Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@ast
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@en
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@en-gb
type
label
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@ast
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@en
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@en-gb
prefLabel
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@ast
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@en
Recent trends in cutaneous mal ...... o stage of disease, 1993-2003.
@en-gb
P2860
P356
P1154
2-s2.0-33745533912
P1476
Recent trends in cutaneous mal ...... to stage of disease, 1993-2003
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6603216
P407
P577
2006-06-06T00:00:00Z
P5875
P6179
1050921134